_edited.png)
RISK CONCERN
Investment Strategy, Risk Analysis, and Insights by Chartered Professionals
HWKN
Primary Facts
Specialty Chemicals
Name:
-
Sector:
12.67M
Industry:
37.99
CEO:
Mr. Patrick Hawkins
Total Employees:
Small Cap
Our Technological Advancement Rating
Our Rating:
-0.530382708
-0.518885353
Hawkins, Inc. (XNAS:HWKN) In-Depth Stock/Fundamental/Options Analysis Today
Primary Targets/Price Insights
Previous Close ($) :
Hawkins, Inc. (XNAS:HWKN)
One Month Price Target:
Six Month Price Target :
$38.17
Likely Price in One Year's Time:
Ticker:
$39.1
Likely Trading Range Today Under (Normal Volatility)
$38.21
Price Upper limit ($) :
$40.21
Price Lower limit ($) :
Crash Risk Prep/Key Price Levels (High Volatility/Risk)
Price, as per data analysis, isn't likely to fall below:
Today:
P477
This week:
$35.87
This month :
$33.25
Other Primary facts
Market Cap:
21.01M
Market Cap Classification:
785.87M
Number of Shares
IPO Date:
B
Best/Worst Daily Performance (Last 3+ Years)
Highest Daily Appreciation:
-15.88%
$28.51
Worst Daily Decline:
Our Options Trading Entry Points
Iron Condor entry points for options expiring in 1 week's time
Low risk (<2%) entry points
Buy Call:
Sell Call:
Buy Put:
Sell Put:
$43.25
18.25%
$32.73
$47.82
Medium risk (<10%) entry points
Buy Call
Sell Call
$40.79
Buy Put:
Sell Put:
$28.16
$35.19
$41.76
These entry points can be used for other strategies, such as butterflies, straddles, etc.
Risk-Adjusted returns (Sharpe Ratio) of
Specialty Chemicals
Sharpe Ratio:
HWKN, is amongst the top 20% highest yielding stocks in terms of daily returns
Comparison:
2.12%
0.840511015
Sharpe ratio is 84.05% higher than the industry
Average Returns/Yield of
Specialty Chemicals
Daily returns:
1
Weekly returns:
0.12%
Monthly returns:
0.59%
Yearly returns:
28.08%
Comparison of returns:
0.142921573
Classification:
Average annual returns/yield (last 3 years) is 14.29% above industry average
Results of T-Test of Returns:
HWKN is a riskier investment compared to Nasdaq (IXIC)
Statistical test of Returns:
0.55
Volatility (measured by Standard Deviation)
Daily Volatility:
& ratio is 71.04% higher than the market/S&P 500 average
Weekly Volatility:
2.77%
Monthly Volatility:
6.20%
Yearly Volatility:
12.41%
Volitlilty of last five days (Measured by Standard Deviation)
Average Volatility of this Week:
54.08%
-48.85%
Value at Risk Analysis (VaR)
Daily VaR:
Volatility in last five trading days has been -48.85% below long-term volatility
Weekly VaR:
-5.58%
Monthly VaR:
-12.48%
How Much Can the price of
Specialty Chemicals
Decline in a Recession?
Likely price decline in a recession:
Base case (decline):
Risk of crash in next 6/12 months: Very high (>70%)
Worst case (decline):
$30.12
This translates to price declining to:
-21%
This translates to price declining to:
-86.45%
Severe Crash Probability
-24.96%
What is Value at Risk (VaR)?
Risk Fundamentals
50.90%
HWKN is a 76.14% riskier investment compared to the market/S&P 500 & is 50.90% riskier than Nasdaq (IXIC)
HWKN is a 76.14% riskier investment compared to the market/S&P 500
Beta Examination of
Specialty Chemicals
0.869
Expected beta in 1 year's time:
0.692
Expected beta in 3 year's time:
0.657
Unlevered (debt free) Beta:
Beta in relation to market/S&P 500--0.87
Beta in relation to Nasdaq (XNAS):
Returns are, approximately, symmetrical
Beta in relation to all global stocks::
Beta is -25.40% below industry average
Beta Comparison & Analysis
Beta of competitors/peers::
0.691
-0.444
Average Industry Beta:
Beta is -44.38% lower than peers
-0.254005773
Sustainable Growth Rate Analysis
Sustainable growth rate for this stock/firm:
WACC is -12.87% below industry mean WACC
-51.48%
Alpha provided | Alpha Analysis
Alpha provided:
0.930
0.412
12.082
Analysis of Cost of Capital of
Specialty Chemicals
Equity cost of capital:
Alpha is 1208% higher than market/& is unsustainably high
-0.182
Unlevered (without debt) cost of capital:
Equity cost of capital is -18.21% below industry mean WACC
Before-tax cost of debt:
7.24%
After-tax cost of debt:
1.31%
Overall debt rating:
1.03%
Weighted average cost of capital (WACC):
1.31%
-12.87%
Key Per-Share Metrics & Analysis
Revenue per share:
Present value of the expected future dividends only: $4.33
Revenue growth rate per share of (3Y):
Price to sales ratio is -62.66% below the industry mean
1048.82%
EPS:
Fifty-One Million Four Hundred Thirty Thousand Three Hundred Twenty Dollars
Expected Annual growth rate of EPS (3Y):
Price to free cash flow ratio is -24.83% lower than the industry
2927.02%
Free cash flow (FCF) per share:
Price to book ratio is -29.15% below the industry mean
-
0.001132815
Debt per share
Debt repayment rate in last quarter: 0.00%
EBITDA per share
Each employee generates 20% more EBITDA than industry average revenue per employee
Valuation Analysis Today of
Specialty Chemicals
P/E Ratio:
Sustainable growth rate is -51.48% below industry average
P/E Ratio of Competitors/Peers:
14.67
-0.608409988
91.40014539
-0.584355147
$0.69
Share value as per dividend discount (DDM) model: $13.51
P/S (Price to Sales ratio):
$36.87
-0.626570358
P/B (Price to book value ratio):
Price to sales ratio is -62.66% below the industry mean
-
-0.248306778
Net income growth rate (3Y):
Annual revenue growth rate is 1048.82% above the industry average
895.93%
Dividend Analysis
Net income growth rate is 895.93% higher than the average industry net income growth rate
Dividend payout rate: 5.04%
$0.14
Previous Dividend: $0.14
Previous adjusted dividend: $0.14
Previous Dividend: $0.54
Expected next dividend best case: $0.18
Expected next dividend worst case: $0.10
Average dividend payment (long-term): $0.19
Average dividend increase/decrease (growth rate) % per period: -2.99%
Expected next dividend payment date: 15/09/2022
Expected next dividend record date: 09/01/2022
-
Previous dividend payment date: 17/06/2022
Previous dividend record date: 06/03/2022
Dividend History:
-
2022-02-17--$0.14
2021-08-12--$0.13
2022-06-02--$0.14
2021-11-04--$0.13
2021-06-03--$0.12
-1.145588956
In-depth Debt & Leverage Analysis
Debt to equity ratio:
37.09%
Net debt to equity ratio:
The remaining useful life of property plant & equipment is: 2.9 years
Debt to assets ratio:
21.49%
Net debt to assets ratio:
34.80%
-62.73%
Ability to repay debt:
Interest coverage ratio:
Debt-to-asset ratio is -62.73% below industry average
2.24
Looking forward:
Debt growth rate:
1.3x
-78.08%
0.00%
Analysis of Key Statistics
Correlation of price movement with the market:
12.65634698
Statistical significance of correlation:
-0.35%
Average Correlation of the industry with the market:
0.436
-24.86%
R Squared (percentage of price movement explained by movement of the market):
0.436
Correlation of price movement with Nasdaq (^IXIC):
0.19
Covariance of price movement with the market:
-0.002
Kurtosis
-0.003
5.563
Skewness of returns:
Returns have moderate fat-tails (leptokurtic), i.e., returns considerably higher or lower than the mean returns are more probable, compared to assets with normally distributed returns
0.327
Fundamental Analysis & Dupont Analysis of
Specialty Chemicals
Gross Profit Margin Ratio:
146.52M
Operating Profit Margin Ratio:
Net profit margin is -102.36% lower than the industry
-103.26%
Net Profit Margin Ratio:
146.52M
Effective Tax Rate:
1.55%
0.467211841
Dupont Method
Net Profit Margin
Return on Equity Ratio (ROE):
×
ROA
=
×
Return on assets (ROA) is 313.19% higher than the industry
-34.85%
Financial Leverage
Asset Turnover Ratio (ROA):
Operating profit margin is -103.26% lower than the industry
313.19%
Financial Leverage:
Interest coverage ratio is 223.53% more than industry average
Current Ratio:
Return on equity (ROE) is -34.85% lower than the industry
-0.059079147
Cash Conversion Cycle (days):
$4.56
-0.409327066
Current ratio is -5.91% below industry average
Stock based compensation to net income ratio:
Equity growth rate per share is 0.11% higher than the industry
In-depth Efficiency Analysis
Revenue generated per employee:
Cash conversion cycle is -40.93% below industry average
0.283828206
EBITDA generated per employee:
Each employee generates 28% more revenue than industry average revenue per employee
0.196432583
Profit generated per employee:
$4.55
101%
Free cash flow (FCF) generated per employee:
Each employee generates 101% more net income/profit than industry average revenue per employee
-1.422424163
Assets/Capital per employee
Each employee generates -142% less free cash flow than industry average revenue per employee
-1.422424163
Research & Development (R&D) Analysis
-
-
Competitors/Peer firms of
Specialty Chemicals
$52.10
FERROGLOBE PLC (XNAS:GSM)
NXEO
UNITED STATES LIME & MINERALS, INC. (XNAS:USLM)
SPDR BBGSASBUSCorpESGUCITSETFA (XLON:USCR)
ADICET BIO, INC. (XNAS:ACET)
PIEDMONT LITHIUM INC. (XNAS:PLL)
MERCER INTERNATIONAL INC. (XNAS:MERC)
OLYMPIC STEEL, INC. (XNAS:ZEUS)
Current Analyst Ratings
$2.44
Strong buy�0%
Buy�0%
Hold�0%
Sell�0%
Strong sell�0%
Income Statement
Period:
4/3/2022
Date:
Value
Revenue:
TTM
Cost of Revenue:
Gross Profit:
R&D Expense
General & Admin Expenses:
Selling, General & Admin Expenses
Sales and Marketing Expenses
Other Expenses :
Operating Expenses :
Cost & Expenses :
Interest Income:
Interest Expenses:
Depreciation & Amortization:
EBITDA:
Operating Income:
Other Income Expenses:
Income Before Tax:
Income Tax Expense:
Net Income:
Balance Sheet
Date:
Calendar Year:
Period:
Cash & Cash Equivalents:
Short Term Investments:
Cash & Short Term Investments:
Net Receivables:
Inventory:
Other Current Assets:
Total Current Assets:
PP&E:
Goodwill:
Intangible Assets:
Long Term Investments:
Tax Assets:
Other Non-Current Assets:
Total Non-Current Assets:
Other Assets:
Total Assets:
Accounts Payable:
Short Term Debt:
Tax Payables:
Deferred Revenue:
Other Current Liabilities:
Total Current Liabilities:
Long Term Debt:
Other Non-Current Liabilities:
Total Non Current Liabilities:
Other Liabilities:
Total Liabilities:
Common Stock:
Retained Earnings:
Accumulated Other Comprehensive Loss:
Other Total Stockholders' Equity:
Total Stockholders' Equity:
Total Liabilities and Stockholders' Equity:
Total Investments:
Total Debt:
Net Debt:
774.54M
628.02M
76%
-
-
75.33M
-
-
703.35M
-
1.40M
24.13M
50%
18.44M
- 1215.00K
37%
18.44M
Statement of Cash Flow
Date:
Period:
16.63M
Differed Income Tax :
5.94M
Stock Based Compensation :
-
Change in Working Capital :
799.00K
Accounts Receivables:
- 8857.00K
Other Working Capital:
868.00K
Other Non-Cash Items:
5.40M
Net Cash Provided by Operating Activities:
316.00K
Investments in PP&E:
14.82M
Net Acquisitions:
- 2155.00K
Purchases of Investments:
-
Sales/Maturities of Investments:
Other Investing Activities:
Net Cash Used for Investing Activities:
Debt Repayment:
Common Stock Issued:
Common Stock Repurchased:
Dividend Paid:
Other Financing Activities:
Net Cash Used Provided by Financing Activities:
Effect of FOREX on Changes in Cash:
Net Changes in Cash:
Cash at End of Period:
Cash at Beginning of Period:
Operating Cash Flow:
Capital Expenditure:
Free Cash Flow (FCF):
Value
6/27/2021
2022
Q1
5.22M
-
5.22M
90.94M
67.94M
3.67M
167.77M
153.68M
70.75M
74.79M
-
-
8.02M
307.24M
-
475.02M
38.05M
11.53M
5.22M
-
16.93M
66.51M
95.78M
13.07M
133.30M
-
199.81M
210.00K
227.93M
- 159707.0K
Value
75.33M
206.78M
275.21M
475.02M
-
107.31M
-
-
26.00K
- 2129.00K
-
-
- 4868.00K
- 2600.00K
- 3000.00K
- 10468.00K
-
2.22M
5.22M
3.00M
14.82M
- 2155.00K
Our Proprietary Portfolio Rating
Our Rating:
-5.1886851
Price Forecast/Expected Price in Next 5 Years of
Specialty Chemicals
2023
2024
2025
2026
2027
41.52459365
$41.52
$43.95
$46.51
$49.23